BackImmix Biopharma Overview

Immix Biopharma Common Stock

Track Immix Biopharma's common stock ($7.2K) with charts, peers, and YoY trends.

Get informed when a big investor buys or sells

+ Follow
Common Stock
$7160.00
↑ 151.49% YoYΔ $4313.00 vs prior year quarter

Peer average / median

Loading

Immix Biopharma Common Stock History

Loading

Immix Biopharma vs. peers: Common Stock Comparison

Loading

Immix Biopharma Common Stock Growth (YoY per quarter)

Latest change versus the prior comparable period (same company). Positive growth indicates new issuance/dilution; negative growth indicates reductions/buybacks.

Loading

Immix Biopharma (IMMX) FAQ

As of the most recent data (June 2026), IMMX shows a common stock of $7.2K. That compares with $2.8K in the prior-year period — up 151.5% year over year. Scroll down for historical charts and peer comparison views.

Compared with the year-ago period, IMMX's common stock is now $7.2K (was $2.8K) — a 151.5% year-over-year increase. Pairing that YoY change with peer averages gives a clearer picture of whether Immix Biopharma is outperforming or lagging.

Tracking IMMX's common stock over time shows whether Immix Biopharma is scaling, shrinking, or reshaping that part of the business. The current reading is $7.2K That compares with $2.8K in the prior-year period — up 151.5% year over year. Multi-quarter patterns matter more than any single print, which is why this page emphasizes history and peer comparison charts.

Besides this common stock page, Stockcircle has Immix Biopharma's full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect common stock (currently $7.2K) with ownership activity and broader fundamentals.